Masimo Corporation (LON:0JZ2)
145.96
-1.85 (-1.25%)
At close: Oct 17, 2025
Masimo Revenue
Masimo had revenue of $370.9 million USD in the quarter ending June 28, 2025, with 7.85% growth. This brings the company's revenue in the last twelve months to $2.15 billion, up 25.86% year-over-year. In the year 2024, Masimo had annual revenue of $2.09 billion with 2.26% growth.
Revenue (ttm)
$2.15B
Revenue Growth
+25.86%
P/S Ratio
3.79
Revenue / Employee
$598.28K
Employees
3,600
Market Cap
5.95B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 28, 2024 | 2.09B | 46.30M | 2.26% |
Dec 30, 2023 | 2.05B | 12.30M | 0.60% |
Dec 31, 2022 | 2.04B | 796.60M | 64.28% |
Jan 1, 2022 | 1.24B | 95.50M | 8.35% |
Jan 2, 2021 | 1.14B | 205.86M | 21.95% |
Dec 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 29, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jan 2, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
GSK plc | 31.63B |
Haleon | 11.02B |
Smith & Nephew | 4.33B |
Hikma Pharmaceuticals | 2.35B |
ConvaTec Group | 1.72B |
Spire Healthcare Group | 1.55B |
Genus | 672.80M |
Masimo News
- 1 day ago - Recent Report Shows That Rep. Kevin Hern Sold Up to $200K Worth of Accenture Stock - Benzinga
- 9 days ago - Masimo to Host Investor Day on December 3, 2025 - Business Wire
- 11 days ago - In Feasibility Study for Large, Prospective, Real-World Trial, Masimo SET® Performed Accurately on Critically Ill Adult ICU Patients of All Skin Tones - Business Wire
- 15 days ago - Why Masimo (MASI) is a Top Growth Stock for the Long-Term - Nasdaq
- 15 days ago - Is the Options Market Predicting a Spike in Masimo Stock? - Nasdaq
- 19 days ago - Here's How Much $100 Invested In Masimo 10 Years Ago Would Be Worth Today - Benzinga
- 22 days ago - Joe Kiani: A Year of Reinvention and Impact Beyond Masimo - CEOWORLD magazine
- 23 days ago - Don't Overlook These 2 Highly Ranked Medical Stocks: COLL, MASI - Nasdaq